Share-based Payment Arrangement, Expense of BIOMERICA INC from 31 May 2018 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIOMERICA INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 May 2018 to 30 Nov 2025.
  • BIOMERICA INC Share-based Payment Arrangement, Expense for the quarter ending 30 Nov 2025 was $72,000, a 54% decline year-over-year.
  • BIOMERICA INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Nov 2025 was $374,000, a 52% decline year-over-year.
  • BIOMERICA INC annual Share-based Payment Arrangement, Expense for 2024 was $460,000, a 45% decline from 2023.
  • BIOMERICA INC annual Share-based Payment Arrangement, Expense for 2023 was $837,000, a 29% decline from 2022.
  • BIOMERICA INC annual Share-based Payment Arrangement, Expense for 2022 was $1,185,000, a 6% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIOMERICA INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $374,000 $72,000 -$83,000 -54% 01 Sep 2025 30 Nov 2025 10-Q 14 Jan 2026 2026 Q2
Q3 2025 $457,000 $74,000 -$3,000 -3.9% 01 Jun 2025 31 Aug 2025 10-Q 14 Oct 2025 2026 Q1
Q2 2025 $460,000 $137,000 -$68,000 -33% 01 Mar 2025 31 May 2025 10-K 29 Aug 2025 2025 FY
Q1 2025 $528,000 $91,000 -$249,000 -73% 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q3
Q4 2024 $777,000 $155,000 +$33,000 +27% 01 Sep 2024 30 Nov 2024 10-Q 14 Jan 2026 2026 Q2
Q3 2024 $744,000 $77,000 -$93,000 -55% 01 Jun 2024 31 Aug 2024 10-Q 14 Oct 2025 2026 Q1
Q2 2024 $837,000 $205,000 +$26,058 +15% 01 Mar 2024 31 May 2024 10-K 29 Aug 2025 2025 FY
Q1 2024 $810,942 $340,000 -$43,828 -11% 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q3
Q4 2023 $854,770 $122,000 -$196,230 -62% 01 Sep 2023 30 Nov 2023 10-Q 14 Jan 2025 2025 Q2
Q3 2023 $1,051,000 $170,000 -$134,000 -44% 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2025 Q1
Q2 2023 $1,185,000 $178,942 -$121,690 -40% 01 Mar 2023 31 May 2023 10-K 28 Aug 2024 2024 FY
Q1 2023 $1,306,690 $383,828 +$58,479 +18% 01 Dec 2022 28 Feb 2023 10-Q 14 Apr 2023 2023 Q3
Q4 2022 $1,248,211 $318,230 +$3,833 +1.2% 01 Sep 2022 30 Nov 2022 10-Q 14 Apr 2023 2023 Q3
Q3 2022 $1,244,378 $304,000 -$15,622 -4.9% 01 Jun 2022 31 Aug 2022 10-Q 12 Oct 2023 2024 Q1
Q2 2022 $1,260,000 $300,632 01 Mar 2022 31 May 2022 10-K 25 Aug 2023 2023 FY
Q1 2022 $325,349 01 Dec 2021 28 Feb 2022 10-Q 14 Apr 2023 2023 Q3
Q4 2021 $314,397 01 Sep 2021 30 Nov 2021 10-Q 14 Apr 2023 2023 Q3
Q3 2021 $319,622 01 Jun 2021 31 Aug 2021 10-Q 14 Apr 2023 2023 Q3

BIOMERICA INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $460,000 -$377,000 -45% 01 Jun 2024 31 May 2025 10-K 29 Aug 2025 2025 FY
2023 $837,000 -$348,000 -29% 01 Jun 2023 31 May 2024 10-K 29 Aug 2025 2025 FY
2022 $1,185,000 -$75,000 -6% 01 Jun 2022 31 May 2023 10-K 28 Aug 2024 2024 FY
2021 $1,260,000 -$95,000 -7% 01 Jun 2021 31 May 2022 10-K 25 Aug 2023 2023 FY
2020 $1,355,000 01 Jun 2020 31 May 2021 10-K 29 Aug 2022 2022 FY
2018 $151,224 +$132,751 +719% 01 Jun 2018 31 May 2019 10-K 29 Aug 2019 2019 FY
2017 $18,473 01 Jun 2017 31 May 2018 10-K 29 Aug 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.